107027-41-8 Usage
Uses
Used in Pharmaceutical Industry:
2-(3-METHOXYPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID is used as a potential pharmaceutical agent for its ability to inhibit the enzyme cdc25B, which is involved in cell cycle regulation. This makes it a candidate for the development of drugs targeting diseases related to abnormal cell proliferation.
Used in Anti-tumor Applications:
In preclinical studies, 2-(3-METHOXYPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID has shown potential as an anti-tumor agent, making it a candidate for further research into its use in cancer treatment. Its activity against tumor cells could be leveraged to develop new therapeutic strategies for various types of cancer.
Used in Drug Development Research:
Due to its unique structure and biological activity, 2-(3-METHOXYPHENYL)-8-METHYLQUINOLINE-4-CARBOXYLIC ACID is used as a target for drug development research. Scientists are interested in exploring its potential to create new medications that could address unmet medical needs, particularly in the areas of cell cycle regulation and cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 107027-41-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,0,2 and 7 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 107027-41:
(8*1)+(7*0)+(6*7)+(5*0)+(4*2)+(3*7)+(2*4)+(1*1)=88
88 % 10 = 8
So 107027-41-8 is a valid CAS Registry Number.
InChI:InChI=1/C18H15NO3/c1-11-5-3-8-14-15(18(20)21)10-16(19-17(11)14)12-6-4-7-13(9-12)22-2/h3-10H,1-2H3,(H,20,21)
107027-41-8Relevant academic research and scientific papers
Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as 'minimal' DNA-intercalating antitumor agents with in vivo solid tumor activity
Atwell,Baguley,Denny
, p. 396 - 401 (2007/10/02)
A series of phenyl-substituted derivatives of the 'minimal' DNA-intercalating agent N-[2-(dimethylamino)-ethyl]-2-phenylquinoline-8-carboxamide (1) have been synthesized and evaluated for in vivo antitumor activity, in a continuing search for active compo